Recuperato da: Thomsen M, Dencker D, Wrtwein G, Weikop P, Egecioglu E, Jerlhag E, et al
In addition to initial FLOW trial findings indicating Ozempic can offer kidney protective benefits, results of Novo Nordisks SELECT trial showed that semaglutide significantly reduced rates of kidney and cardiovascular events compared with placebo in participants with overweight and obesity with cardiovascular disease but without diabetes
At the most basic level, glutathione cycles between a reduced form (GSH) and an oxidized form (GSSG)
Reaksi alergi bisa terjadi pada sebagian orang, terutama jika memiliki riwayat sensitivitas terhadap suplemen tertentu
A narrative review of current and emerging trends in the treatment of alcohol use disorder trends in the treatment of alcohol use disorder